Yet Another Amyloidosis

Abstract

Keywords

amyloidosis kidney diseases liver diseases

Get full access to this article

View all access options for this article.

References

Muchtar

, Dispenzieri

, Magen

, . Systemic amyloidosis from a (AA) to T (ATTR): a review. J Intern Med 2021;289:268–92.doi:10.1111/joim.13169http://www.ncbi.nlm.nih.gov/pubmed/32929754

Shohat

, Halpern

. Familial Mediterranean fever–a review. Genet Med 2011;13:487–98.doi:10.1097/GIM.0b013e3182060456http://www.ncbi.nlm.nih.gov/pubmed/21358337

Palladini

, Milani

, Merlini

. Management of AL amyloidosis in 2020. Blood 2020;136:2620–7.doi:10.1182/blood.2020006913http://www.ncbi.nlm.nih.gov/pubmed/33270858

Brunger

, Nienhuis

HLA

, Bijzet

, . Causes of AA amyloidosis: a systematic review. Amyloid 2020;27:1–12.doi:10.1080/13506129.2019.1693359http://www.ncbi.nlm.nih.gov/pubmed/31766892

Sekijima

. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry 2015;86:1036–43.doi:10.1136/jnnp-2014-308724http://www.ncbi.nlm.nih.gov/pubmed/25604431

Mann

, Bhandohal

, Cobos

, . LECT-2 amyloidosis: what do we know? J Investig Med 2021. doi:10.1136/jim-2021-002149. [Epub ahead of print: 30 Nov 2021].http://www.ncbi.nlm.nih.gov/pubmed/34848562